S S Ganguly
Overview
Explore the profile of S S Ganguly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
171
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Watson M, Berger P, Banerjee K, Frank S, Tang L, Ganguly S, et al.
Oncogene
. 2021 Apr;
40(18):3260-3272.
PMID: 33846571
The molecular mechanisms of luminal cell differentiation are not understood well enough to determine how differentiation goes awry during oncogenesis. Using RNA-Seq analysis, we discovered that CREB1 plays a central...
2.
Kapilashrami M, Virk R, Ganguly S, Chatterjee K
Med J Armed Forces India
. 2017 Aug;
56(2):113-116.
PMID: 28790672
Low birth weight (LBW) is responsible for a significant proportion of child morbidity and mortality apart from its possible role in the occurrence of chronic disease in adult life. This...
3.
Gujjar A, Jacob P, Nandhagopal R, Ganguly S, Obaidy A, Al-Asmi A
J Crit Care
. 2012 Aug;
28(3):316.e1-8.
PMID: 22884530
Purpose: Full Outline of UnResponsiveness, or FOUR score (FS), is a recently described scoring system for evaluation of altered sensorium. This study examined interrater reliability for FS and Glasgow Coma...
4.
Ganguly S, Fiore L, Sims J, Friend J, Srinivasan D, Thacker M, et al.
Oncogene
. 2011 Sep;
31(14):1804-16.
PMID: 21892207
Despite 35 years of clinical trials, there is little improvement in 1-year survival rates for patients with metastatic melanoma, and the disease is essentially untreatable if not cured surgically. The...
5.
Machado N, Grant C, Alkindi S, Daar S, Al-Kindy N, Al Lamki Z, et al.
Int J Surg
. 2009 Aug;
7(5):476-81.
PMID: 19695352
Background: Haematological disorders, in particular sickle cell disease (SCD) and thalassaemia, are relatively common in Oman. We report our experience of splenectomy for haematological disorders and review the literature on...
6.
Ganguly S, Al-Lawati A, Al-Shafaee M, Duttagupta K
World Hosp Health Serv
. 2009 Aug;
45(1):26-31.
PMID: 19670522
During the past 35 years Oman has undergone a rapid socioeconomic and epidemiological transition leading to a steep reduction in child and adult mortality and morbidity due to the decline...
7.
Ganguly S, Al-Shafaee M, Al-Lawati J, Dutta P, Duttagupta K
East Mediterr Health J
. 2009 May;
15(1):209-18.
PMID: 19469445
During the past 35 years Oman has undergone a rapid socioeconomic and epidemiological transition leading to a steep reduction in child and adult mortality and morbidity due to the decline...
8.
Bialasiewicz A, Breidenbach K, Ganesh A, Al-Saeidi R, Ganguly S
Ophthalmologe
. 2006 Jul;
103(10):877-87.
PMID: 16821074
Background: Oman is a developing country of the Middle East with a University Hospital in a national health system. Problems related to documentation, structure, and procedure prevailing in a multicultural...
9.
Al-Moundhri M, Al-Bahrani B, Burney I, Nirmala V, Al-Madhani A, Al-Mawaly K, et al.
Oncology
. 2006 Apr;
70(2):90-6.
PMID: 16601367
Background: Gastric cancer is the most common cancer in Oman and a leading cause of cancer death. The variation in survival rates between countries and ethnic groups has been attributed...
10.
Al-Moundhri M, Nirmala V, Al-Hadabi I, Al-Mawaly K, Burney I, Al-Nabhani M, et al.
J Surg Oncol
. 2005 Aug;
91(4):243-52.
PMID: 16121348
Background: The variability of prognosis within a pathological stage of gastric cancer (GC) at presentation, underscores the need for specific biological markers to identify subgroups of patients with aggressive course...